Title: Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.
Journal: Journal of medicinal chemistry 20120308
100524-24-1
5334-99-6
5334-49-6
862728-61-8
5334-72-5
303145-59-7 | 5-(4-fluorophenyl)-4H,5H-thieno[2,3-d]pyridazine | AA00IUKW | MFCD00232237
882748-49-4 | 3-[(3-fluoro-4-methylphenyl)amino]-1-(3-nitrophenyl)propan-1-one | AA00IUOM | MFCD03932058
1190198-18-5 | 2-(Benzylamino)-5-iodonicotinic acid | AA00IURC | MFCD12922691
1353878-06-4 | 4-Oxo-4H-pyrido[1,2-a]pyrimidine-9-carbaldehyde | AA00IUU8 | MFCD20444446
685109-22-2 | ethyl 4-{[3-(dimethylamino)propyl]amino}-1-methyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate | AA00IUX7 | MFCD03617622
866156-41-4 | (2E)-2-cyano-3-(4-ethoxyphenyl)-N-[4-(trifluoromethyl)phenyl]prop-2-enamide | AA00IUZY | MFCD05669873
195243-37-9 | 2-[(4-phenylpiperazin-1-yl)methylidene]propanedinitrile | AA00IV2Y | MFCD00129546
328585-95-1 | N'-[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]thiophene-2-carbohydrazide | AA00IV65 | MFCD00245616
866010-08-4 | N-[(4-chlorophenyl)methyl]-4-(4-methoxyphenyl)-1,3-thiazol-2-amine | AA00IVBQ | MFCD05670328
1171919-29-1 | 2,4,6-Trichlorophenyl 2-cyanobenzenesulfonate | AA00IVDW | MFCD12498725